Business Wire05.02.17
KKR, along with Aisling Capital, has announced the creation of a new platform, Ajax Health, which will source and provide operational and financial capabilities to a diversified portfolio of emerging medical device companies under the leadership of Duke Rohlen. Rohlen is a 15-year medical device veteran who has served as president of FoxHollow Technologies and founder and CEO of CV Ingenuity. Rohlen successfully sold these businesses to strategic acquirers for aggregate consideration in excess of $1 billion.
“There is a significant need in the medical device space not only for capital but also for operational expertise and guidance,” said Rohlen. “With Ajax Health, we are eager to provide the resources necessary to enable companies to provide innovative medical treatments for the millions of people who need them.”
“KKR is excited to partner with Duke Rohlen—a proven executive in the medical device industry. He has a fantastic track record of identifying and growing companies through his strategic thinking and the recruitment of strong management talent,” said Jim Momtazee, member of KKR and head of KKR’s Health Care industry team.
For KKR, the investment is from its healthcare growth equity fund, which is focused on high-growth companies for which KKR can be a unique partner in helping reach scale.
Hear from Duke Rohlen in the following video.
“There is a significant need in the medical device space not only for capital but also for operational expertise and guidance,” said Rohlen. “With Ajax Health, we are eager to provide the resources necessary to enable companies to provide innovative medical treatments for the millions of people who need them.”
“KKR is excited to partner with Duke Rohlen—a proven executive in the medical device industry. He has a fantastic track record of identifying and growing companies through his strategic thinking and the recruitment of strong management talent,” said Jim Momtazee, member of KKR and head of KKR’s Health Care industry team.
For KKR, the investment is from its healthcare growth equity fund, which is focused on high-growth companies for which KKR can be a unique partner in helping reach scale.
Hear from Duke Rohlen in the following video.